Published in Synapse on July 01, 1997
Depressive symptoms in adolescents: associations with white matter volume and marijuana use. J Child Psychol Psychiatry (2007) 1.38
Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol (2009) 1.29
Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system? Life Sci (2012) 1.27
Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology (Berl) (2007) 1.25
Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res (2010) 1.18
Hedonic sensitivity in adolescent and adult rats: taste reactivity and voluntary sucrose consumption. Pharmacol Biochem Behav (2009) 1.18
Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats. J Pharmacol Exp Ther (2006) 1.14
Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci (2009) 1.06
"Binge" drinking experience in adolescent mice shows sex differences and elevated ethanol intake in adulthood. Horm Behav (2009) 1.05
Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology (Berl) (2013) 1.04
The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci (2009) 1.04
Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Front Neurosci (2014) 0.96
Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex. Neuroscience (2007) 0.95
Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl) (2010) 0.93
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways. Br J Pharmacol (2011) 0.89
Functional connectivity and cannabis use in high-risk adolescents. Am J Drug Alcohol Abuse (2013) 0.89
The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription. Br J Pharmacol (2012) 0.88
Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb Cortex (2009) 0.87
Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. Mini Rev Med Chem (2009) 0.84
Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. Front Behav Neurosci (2012) 0.83
Developmental regulation of fear learning and anxiety behavior by endocannabinoids. Genes Brain Behav (2015) 0.82
Comparison of Cannabinoid CB(1) Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [F]MK-9470. Int J Mol Imaging (2011) 0.80
Cannabinoid mitigation of neuronal morphological change important to development and learning: insight from a zebra finch model of psychopharmacology. Life Sci (2012) 0.77
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol lipase does not cause neurodegeneration in neonatal mice. J Neurochem (2015) 0.77
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling. Brain Sci (2015) 0.76
Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis? Cell Adh Migr (2008) 0.76
Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of threat. Dev Cogn Neurosci (2015) 0.75
Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model. Dev Growth Differ (2017) 0.75
For whom the bird sings: context-dependent gene expression. Neuron (1998) 4.01
Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci (1994) 1.58
Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun (2000) 1.58
Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun (1999) 1.58
Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport (1993) 1.55
Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci (1999) 1.49
Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse (1999) 1.44
The endogenous cannabinoid system and brain development. Trends Neurosci (2000) 1.28
A microbiological, histopathological and immunohistological study of the intragastric inoculation of Listeria monocytogenes in mice. J Comp Pathol (1992) 1.17
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. J Neurochem (2000) 1.16
Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem Biophys Res Commun (2000) 1.15
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J Neurochem (2001) 1.13
Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development (1998) 1.11
Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res Mol Brain Res (1997) 1.07
Fatty acid synthetase activity in Mycobacterium smegmatis. Characterization of the acyl carrier protein-dependent elongating system. Biochim Biophys Acta (1977) 1.03
Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse (1998) 1.01
Porcine epidemic abortion and respiratory syndrome (mystery swine disease). Isolation in Spain of the causative agent and experimental reproduction of the disease. Vet Microbiol (1992) 1.01
Choroiditis and meningitis in experimental murine infection with Listeria monocytogenes. Eur J Clin Microbiol Infect Dis (1992) 1.00
Effect of inhaled dust mite allergen on regional particle deposition and mucociliary clearance in allergic asthmatics. Clin Exp Allergy (2011) 0.98
Identification of Leishmania donovani amastigotes in canine tissues by immunoperoxidase staining. Res Vet Sci (1988) 0.97
Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. Eur J Neurosci (2001) 0.96
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. J Med Chem (2001) 0.94
Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol Biochem Behav (1995) 0.93
Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim Biophys Acta (1998) 0.92
The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci (1995) 0.92
Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res (1995) 0.92
Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol Biochem Behav (1994) 0.91
Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav (1994) 0.91
An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behav Brain Res (1993) 0.90
The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. Eur Psychiatry (2003) 0.90
Do ticks and Borrelia burgdorferi s.l. constitute a burden to birds? Parasitol Res (2013) 0.90
Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience (1998) 0.89
Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen. Life Sci (2000) 0.89
Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Synapse (2001) 0.88
Pneumonia associated with Salmonella choleraesuis infection in swine: 99 cases (1987-1990). J Am Vet Med Assoc (1992) 0.88
Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: prevention of cell death by dibutyryl cyclic AMP. J Neurochem (1995) 0.88
The TaqIA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients. Eur Psychiatry (2005) 0.88
Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Res (1998) 0.88
Neurochemical basis of cannabis addiction. Neuroscience (2011) 0.88
Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease. Brain Res (2002) 0.87
Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol Psychiatry (2003) 0.87
Rapid detection of Actinobacillus actinomycetemcomitans, Prevotella intermedia and Porphyromona gingivalis by multiplex PCR. J Periodontal Res (1998) 0.87
Role of endocannabinoids in brain development. Life Sci (1999) 0.87
Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain. Brain Res Mol Brain Res (1998) 0.86
delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens. J Neural Transm Gen Sect (1993) 0.86
Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences. Brain Res Dev Brain Res (2000) 0.85
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease. Neuroreport (2001) 0.84
Birds as reservoirs for Borrelia burgdorferi s.l. in Western Europe: circulation of B. turdi and other genospecies in bird-tick cycles in Portugal. Environ Microbiol (2012) 0.84
Effects of estrogens and progesterone on the catecholaminergic activity of the adrenal medulla in female rats. Life Sci (1988) 0.84
Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand. Life Sci (1996) 0.84
Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation. Life Sci (1998) 0.84
Chronic colitis due to Leishmania infection in two dogs. Vet Pathol (1991) 0.84
Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. J Neuroendocrinol (1999) 0.84
Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochem Pharmacol (1998) 0.83
Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide. Neurochem Int (1999) 0.83
Endocannabinoids and basal ganglia functionality. Prostaglandins Leukot Essent Fatty Acids (2002) 0.82
Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas. Pharmacol Biochem Behav (1992) 0.82